How do waiting times during diagnosis affect psychological and physiological stress in men with suspected prostate cancer?

Not Applicable

Suspended

• Conditions: Prostate cancer; Cancer; Malignant neoplasm of prostate

• Registration Number: ISRCTN45953686
• Lead Sponsor: Örebro University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-11-22
• Last Update Posted: 18 May 2020
• Study Completion: 2022-12-31

Recruitment & Eligibility

• Status: Suspended
• Sex: Male
• Target Recruitment: 400

Inclusion Criteria

1. Referred to the Urology Department at Örebro University Hospital for suspected prostate cancer
2. Male
3. Aged 85 years or younger
4. Able to speak and write Swedish

Exclusion Criteria

1. Signs of advanced prostate cancer. Metastatic prostate cancer and cancer with prostate-specific antigen level (PSA) >100 mg/l are defined as advanced prostate cancer
2. Severe psychiatric or somatic diseases
3. Any other malignancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> At baseline, 1, 6 and 12 months:<br> 1. Depression and anxiety with the Hospital Anxiety and Depression Scale (HADS)<br> 2. Self-evaluated distress with the National Comprehensive Cancer Network (NCCN) distress thermometer<br> 3. Sleep quality and disturbances through the Åkerstedts Karolinska Sleep Questionnaire<br>

Secondary Outcome Measures

Name	Time	Method
<br> At baseline, 1, 6 and 12 months:<br> 1. Heart rate variability measured using thumb-ECG<br> 2. Diurnal cortisol level measured using saliva cortisol<br>